We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

62 hedge funds and large institutions have $82.2M invested in abrdn Life Sciences Investors in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

1% more capital invested

Capital invested by funds: $81.3M → $82.2M (+$844K)

0.6% more ownership

Funds ownership: 19.28% → 19.87% (+0.6%)

11% less funds holding

Funds holding: 70 → 62 (-8)

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
62
Holders Change
-8
Holders Change %
-11.43%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
29
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAM
Advisors Asset Management
Colorado
+$1.18M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$789K
3
Wells Fargo
Wells Fargo
California
+$728K
4
Ameriprise
Ameriprise
Minnesota
+$666K
5
UR
USCA RIA
Texas
+$626K

Top Sellers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
-$1.17M
2
AWM
AE Wealth Management
Kansas
-$679K
3
CRC
Curi RMB Capital
Illinois
-$661K
4
SS
Simplicity Solutions
Minnesota
-$588K
5
LCM
Landscape Capital Management
New Jersey
-$305K
Name Holding Trade Value Shares
Change 		Change in
Stake
UR
26
USCA RIA
Texas
$614K +$626K +34,941 New
Commonwealth Equity Services
27
Commonwealth Equity Services
Massachusetts
$534K -$55.6K -3,104 -9%
Citigroup
28
Citigroup
New York
$459K +$49.2K +2,747 +12%
GC
29
Guggenheim Capital
Illinois
$447K +$61.5K +3,433 +16%
NFG
30
Next Financial Group
Texas
$424K +$27.3K +1,526 +7%
First Trust Advisors
31
First Trust Advisors
Illinois
$381K -$24.2K -1,350 -6%
AUB
32
Atlantic Union Bankshares
Virginia
$355K +$5.66K +316 +2%
SFS
33
Shaker Financial Services
Virginia
$329K – – –
SKK
34
Shepherd Kaplan Krochuk
Massachusetts
$326K – – –
Stifel Financial
35
Stifel Financial
Missouri
$312K -$14K -783 -4%
SI
36
Stephens Inc
Arkansas
$264K +$37.3K +2,084 +16%
PIA
37
Powell Investment Advisors
Florida
$259K – – –
CAN
38
Claraphi Advisory Network
United States
$257K +$9.29K +519 +4%
OC
39
Oppenheimer & Co
New York
$250K -$191K -10,679 -43%
LOPW
40
Live Oak Private Wealth
North Carolina
$232K – – –
COLIM
41
City of London Investment Management
United Kingdom
$231K +$43K +2,400 +22%
WEC
42
Winslow Evans & Crocker
Massachusetts
$229K +$4.26K +238 +2%
QCIG
43
Quad-Cities Investment Group
Iowa
$189K +$36 +2 +0%
PA
44
Parallel Advisors
California
$181K – – –
JMPWA
45
JP Morgan Private Wealth Advisors
California
$180K +$3.35K +187 +2%
EP
46
Eudaimonia Partners
Tennessee
$129K +$2.96K +165 +2%
Bessemer Group
47
Bessemer Group
New Jersey
$119K – – –
ASN
48
Advisory Services Network
Georgia
$102K +$104K +5,794 New
KTC
49
Kistler-Tiffany Companies
Pennsylvania
$49K +$50.1K +2,800 New
RE
50
RBC Europe
United Kingdom
$47.1K – – –
1
2
3

HQL Hedge Fund Activity: Q3 2020 in Review

62 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2020, worth a combined $82.2M — up 1% from $81.3M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HQL and 6 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 29 added.

The largest buyer was Advisors Asset Management, adding an estimated $1.18M. The largest seller was Karpus Investment Management, exiting entirely with an estimated $1.17M sold.

  • 62 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2020, down from 70 in Q2 2020.
  • Funds reported $82.2M of abrdn Life Sciences Investors stock for Q3 2020, up 1% quarter-over-quarter.
  • 6 funds opened new abrdn Life Sciences Investors positions in Q3 2020 and 13 closed out, a net change of -7 holders.
  • The largest abrdn Life Sciences Investors buyer in Q3 2020 was Advisors Asset Management, an estimated $1.18M added.
  • The largest abrdn Life Sciences Investors seller in Q3 2020 was Karpus Investment Management, an estimated $1.17M sold.

Based on aggregated 13F filings for Q3 2020.